701-1097

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2014-01-01

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-21 (study day 52.0); relationship: POSSIBLE

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-21 (study day 52.0); relationship: POSSIBLE

mild assessed

Mild APPLICATION SITE VESICLES — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 51.0); relationship: PROBABLE

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-03 (study day 3.0); relationship: POSSIBLE

mild assessed

Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: NONE

mild assessed

Mild PHARYNGOLARYNGEAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: NONE

moderate assessed

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 51.0); relationship: POSSIBLE

moderate assessed

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-03-21 (study day 80.0); relationship: POSSIBLE

moderate assessed

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-03-31 (study day 90.0); relationship: POSSIBLE

moderate assessed

Moderate PRURITUS GENERALISED — outcome: RECOVERED/RESOLVED; onset 2014-04-19 (study day 109.0); relationship: POSSIBLE

Data queries

No data queries.